PT Diastika Biotekindo Tbk (IDX:CHEK)
Indonesia · Delayed Price · Currency is IDR
137.00
-1.00 (-0.72%)
At close: Mar 27, 2026
Revenue by Segment
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
|---|
Clinical Diagnostic Group | 116.98B | 108.15B | 100.67B |
Clinical Diagnostic Group Growth | 8.17% | 7.43% | - |
| 37.81B | 20.95B | 16.80B |
Life Science Group Growth | 80.46% | 24.68% | - |
| 154.79B | 129.10B | 117.47B |
| 19.90% | 9.90% | - |
Revenue by Geography
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
|---|
| 154.79B | 129.10B | 117.47B |
| 19.90% | 9.90% | - |
| 154.79B | 129.10B | 117.47B |
| 19.90% | 9.90% | - |
Source: S&P Global Market Intelligence.